Colorectal Disease, published by Wiley, is a premier journal dedicated to advancing research and clinical practice in the field of gastroenterology. With an impressive impact factor and ranked in the Q1 category for Gastroenterology according to 2023 metrics, this journal serves as a vital platform for researchers, clinicians, and students alike. Covering a diverse range of topics from clinical trials to innovative treatment practices, Colorectal Disease strives to disseminate high-quality research that informs effective treatment strategies for colorectal conditions. Since its inception in 1999, the journal has established itself as an essential resource, with its contributions placing it in the 76th percentile among its peers in Scopus rankings. While the journal is not open access, it provides a wealth of knowledge and insights that are crucial for anyone involved in gastrointestinal research and practice. The journal’s address is 111 River Street, Hoboken, NJ 07030-5774, United Kingdom, where it continues to champion excellence in colorectal health research until the end of 2024.

DISEASES OF THE ESOPHAGUS is a prestigious, peer-reviewed journal published by Oxford University Press Inc, focusing on the clinical and translational aspects of esophageal diseases. With an ISSN of 1120-8694 and an E-ISSN of 1442-2050, this journal has cultivated a reputation for excellence since its inception in 1988. Its impact is underscored by its prestigious Q1 ranking in both Gastroenterology and Medicine (miscellaneous) categories as of 2023, positioning it among the top tier of journals within these fields. The journal's scholarly contributions span a wide range of topics relevant to researchers, healthcare professionals, and clinical practitioners, emphasizing advancement in diagnosis and treatment of esophageal conditions. Although currently not an open-access journal, its content is widely accessible through institutional libraries, ensuring that valuable research reaches the hands of those dedicated to enhancing patient care. As it continues publishing through 2024, DISEASES OF THE ESOPHAGUS remains an essential resource for those engaged in understanding and managing esophageal health.

COLOPROCTOLOGY is a specialized journal published by Springer, dedicated to advancing knowledge and understanding in the fields of Gastroenterology and Surgery. With an ISSN of 0174-2442 and an E-ISSN of 1615-6730, this journal holds a prominent position in the medical literature, despite being categorized in the Q4 quartile as per the latest metrics for both disciplines. The convergence of research published from 1998 to 2024 reflects the journal's long-standing commitment to addressing critical issues in coloproctology, offering insights into clinical practices, surgical techniques, and gastrointestinal disorders. While the journal does not currently provide open access options, it remains a vital resource for professionals, researchers, and students aiming to enhance their understanding of complex gastrointestinal health challenges. With its esteemed publisher, Springer, COLOPROCTOLOGY aims to foster innovation and scholarly dialogue within the medical community.

International Journal of Colorectal Disease is a prestigious peer-reviewed journal published by Springer that focuses on the evolving landscape of colorectal diseases. Established in 1986, this journal has served as a vital platform for researchers, healthcare professionals, and students to explore groundbreaking research, innovative treatment methodologies, and the latest advancements in gastroenterology. With an impressive impact factor and ranked in the Q2 category of gastroenterology by Scopus, it holds a prominent position in the academic community, currently occupying the 59th rank among 167 journals in the field, corresponding to the 64th percentile. Although it does not offer open access, the journal remains invaluable for those seeking in-depth analysis and comprehensive insights into colorectal health issues. As it continues through its convergence years until 2024, the International Journal of Colorectal Disease invites contributions that aim to bridge the gap between research and clinical practice, fostering a deeper understanding of colorectal disorders and enhancing patient care.

NEUROGASTROENTEROLOGY AND MOTILITY, published by WILEY, is a premier journal that has significantly contributed to the fields of gastroenterology, neuroscience, and physiology since its inception in 1989. With a robust impact factor and a solid ranking within the top quartile (Q1) of its categories, it reflects the journal's dedication to advancing knowledge and understanding of the complex interplay between the nervous system and gastrointestinal function. With its ISSN 1350-1925 and E-ISSN 1365-2982, the journal is well-regarded among researchers and professionals, highlighting significant developments contributing to both clinical practice and fundamental science. The journal is hosted in the United Kingdom and has established an international reach, offering thought-provoking studies, reviews, and meta-analyses that address critical questions in neurogastroenterology. Although currently not an open-access publication, it ensures that quality research remains accessible to a wide audience through institutional subscriptions. NEUROGASTROENTEROLOGY AND MOTILITY thus stands as a vital resource for those seeking to deepen their understanding of gastrointestinal motility and its neurological controls.

Visceral Medicine is a distinguished journal published by KARGER, specializing in the fields of gastroenterology and surgery. With an ISSN of 2297-4725 and an E-ISSN of 2297-475X, this journal has secured its place in the academic landscape since its inception in 2016, maintaining a consistent quality of research and fostering advancements in visceral health through the year 2024. With notable rankings within the 2nd quartile (Q2) for both gastroenterology and surgery categories, Visceral Medicine ranks #101 out of 551 in the Medicine & Surgery category and #67 out of 167 in Gastroenterology according to Scopus, reflecting its significant impact and relevance in the pursuit of scientific knowledge. Despite not being an open access journal, it provides valuable insights and original research aimed at professionals, researchers, and students keen on expanding their understanding of visceral diseases and innovative surgical techniques. The journal is headquartered in Basel, Switzerland, contributing to its reputation as a hub for high-quality scholarly communication within the medical community.

Gastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.

JOURNAL OF GASTROINTESTINAL SURGERY, published by Elsevier Science Inc, is a premier academic journal dedicated to advancing the field of gastrointestinal surgery. Since its inception in 1997, this journal has served as a vital resource for researchers, clinicians, and students, providing a platform for the dissemination of high-quality original research, reviews, and innovative surgical techniques. With a solid impact factor and ranked Q1 in Surgery and Q2 in Gastroenterology as of 2023, it boasts an impressive Scopus ranking that highlights its influence in both medical and surgical spheres. Situated in the United States, the journal emphasizes the importance of peer-reviewed research that contributes to improved surgical practices and patient outcomes. Although currently not offering open access, its robust editorial policies ensure rigorous quality control, making it an essential reference for anyone involved in gastrointestinal research and surgery.

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

Therapeutic Advances in Gastroenterology, published by SAGE Publications Ltd, is a premier open access journal dedicated to the advancement of knowledge in the field of gastroenterology. Since its inception in 2008 and its transition to open access in 2018, the journal has consistently provided high-quality peer-reviewed research articles, review papers, and clinical studies that address the latest therapeutic advancements and challenges in gastrointestinal medicine. With an impressive impact factor and a 2023 Scopus ranking placing it in the Q1 quartile of gastroenterology journals, it stands as a leading platform for researchers, clinicians, and healthcare professionals. The journal’s commitment to disseminating impactful research has positioned it at the forefront of academic discourse, offering a vital resource for those devoted to improving patient outcomes in digestive health. The United Kingdom-based journal invites submissions that contribute to the understanding and treatment of gastrointestinal disorders, ensuring that cutting-edge findings reach a global audience.